| Nov 6 |
GoodRx accused of conspiring with PBMs over reimbursement fees
|
| Nov 6 |
GoodRx (GDRX) Q3 Earnings Preview: What You Should Know Beyond the Headline Estimates
|
| Oct 31 |
GoodRx Unveils New E-commerce Platform, Launches with Opill®
|
| Oct 29 |
GoodRx to offer low cost Qsymia for weight loss
|
| Oct 29 |
GoodRx stock moves on exclusive 30-day offer of weight management drug Qsymia
|
| Oct 29 |
GoodRx Announces Exclusive Low Cash Price for QSYMIA®, the Leading Branded Once-Daily Oral Weight Management Medication for Adults
|
| Oct 28 |
Ronald E. Bruehlman Joins GoodRx Board of Directors
|
| Oct 26 |
GoodRx: The Tide Is Turning The Wrong Way (Rating Downgrade)
|
| Oct 23 |
GoodRx Announces New Affordability Programs for Menopause Hormone Therapies
|
| Oct 16 |
GoodRx to offer pay-over-time option with Affirm
|
